(Reuters) - Salix Pharmaceuticals Ltd slashed its full-year forecast on Thursday and said inventory for its key drugs piled up, an issue that people familiar with the matter said dissuaded Allergan Inc from acquiring the drugmaker.
via Reuters: Health News Read More Here..
No comments:
Post a Comment